Lifeboat Foundation

Physicists have created a broadband detector of terahertz radiation based on graphene. The device has potential for applications in communication and next-generation information transmission systems, security, and medical equipment. The study came out in ACS Nano Letters.

The new detector relies on the interference of plasma waves. Interference as such underlies many technological applications and everyday phenomena. It determines the sound of musical instruments and causes the rainbow colors in soap bubbles, along with many other effects. The interference of electromagnetic waves is harnessed by various spectral devices used to determine the chemical composition, physical and other properties of objects — including very remote ones, such as stars and galaxies.

Plasma waves in metals and semiconductors have recently attracted much attention from researchers and engineers. Like the more familiar acoustic waves, the ones that occur in plasmas are essentially density waves, too, but they involve charge carriers: electrons and holes. Their local density variation gives rise to an electric field, which nudges other charge carriers as it propagates through the material. This is similar to how the pressure gradient of a sound wave impels the gas or liquid particles in an ever expanding region. However, plasma waves die down rapidly in conventional conductors.

Virtual reality software which allows researchers to ‘walk’ inside and analyse individual cells could be used to understand fundamental problems in biology and develop new treatments for disease.

The software, called vLUME, was created by scientists at the University of Cambridge and 3D image analysis software company Lume VR Ltd. It allows super-resolution microscopy data to be visualised and analysed in virtual reality, and can be used to study everything from individual proteins to entire cells. Details are published in the journal Nature Methods.

Super-resolution microscopy, which was awarded the Nobel Prize for Chemistry in 2014, makes it possible to obtain images at the nanoscale by using clever tricks of physics to get around the limits imposed by light diffraction. This has allowed researchers to observe molecular processes as they happen. However, a problem has been the lack of ways to visualise and analyse this data in three dimensions.

In first-of-their-kind observations in the human brain, an international team of researchers has revealed two well-known neurochemicals–dopamine and serotonin–are at work at sub-second speeds to shape how people perceive the world and take action based on their perception.

Furthermore, the neurochemicals appear to integrate people’s perceptions of the world with their actions, indicating dopamine and serotonin have far more expansive roles in the human nervous system than previously known.

Known as neuromodulators, dopamine and serotonin have traditionally been linked to reward processing–how good or how bad people perceive an outcome to be after taking an action.

Continue reading “Scientists find neurochemicals have unexpectedly profound roles in the human brain” »

In the search for the chemical origins of life, researchers have found a possible alternative path for the emergence of the characteristic DNA pattern: According to the experiments, the characteristic DNA base pairs can form by dry heating, without water or other solvents. The team led by Ivan Halasz from the Rudjer Boskovic Institute and Ernest Mestrovic from the pharmaceutical company Xellia presents its observations from DESYs X-ray source PETRA III in the journal Chemical Communications.

“One of the most intriguing questions in the search for the origin of life is how the chemical selection occurred and how the first biomolecules formed,” says Tomislav Stolar from the Rudjer Boskovic Institute in Zagreb, the first author on the paper. While living cells control the production of biomolecules with their sophisticated machinery, the first molecular and supramolecular building blocks of life were likely created by pure chemistry and without enzyme catalysis. For their study, the scientists investigated the formation of nucleobase pairs that act as molecular recognition units in the Deoxyribonucleic Acid (DNA).

Our genetic code is stored in the DNA as a specific sequence spelled by the nucleobases adenine (A), cytosine ©, guanine (G) and thymine (T). The code is arranged in two long, complementary strands wound in a double-helix structure. In the strands, each nucleobase pairs with a complementary partner in the other strand: adenine with thymine and cytosine with guanine.

This week Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in chemistry for developing a process to edit DNA known as CRISPR Cas-9. But the announcement, which comes amid a years-long battle over who owns the methodology to make genomic edits, is bittersweet.

“In previous work, the researchers discovered that when optical matter is exposed to circularly polarized light, it rotates as a rigid body in the direction opposite the polarization rotation. In other words, when the incident light rotates one way the optical matter array responds by spinning the other. This is a manifestation of “negative torque”. The researchers speculated that a machine could be developed based on this new phenomenon.

In the new work, the researchers created an optical matter machine that operates much like a mechanical machine based on interlocking gears. In such machines, when one gear is turned, a smaller interlocking gear will spin in the opposite direction. The optical matter machine uses circularly polarized light from a laser to create a nanoparticle array that acts like the larger gear by spinning in the optical field. This “optical matter gear” converts the circularly polarized light into orbital, or angular, momentum that influences a nearby probe particle to orbit the nanoparticle array (the gear) in the opposite direction.”

Researchers have developed a tiny new machine that converts laser light into work. These optically powered machines self-assemble and could be used for nanoscale manipulation of tiny cargo for applications such as nanofluidics and particle sorting.

Continue reading “Nanoscale machines convert light into work” »

One of the most remarkable recent advances in biomedical research has been the development of highly targeted gene-editing methods such as CRISPR that can add, remove, or change a gene within a cell with great precision. The method is already being tested or used for the treatment of patients with sickle cell anemia and cancers such as multiple myeloma and liposarcoma, and today, its creators Emmanuelle Charpentier and Jennifer Doudna received the Nobel Prize in chemistry.

While gene editing is remarkably precise in finding and altering genes, there is still no way to target treatment to specific locations in the body. The treatments tested so far involve removing blood stem cells or immune system T cells from the body to modify them, and then infusing them back into a patient to repopulate the bloodstream or reconstitute an immune response—an expensive and time-consuming process.

Building on the accomplishments of Charpentier and Doudna, Tufts researchers have for the first time devised a way to directly deliver gene-editing packages efficiently across the blood brain barrier and into specific regions of the brain, into immune system cells, or to specific tissues and organs in mouse models. These applications could open up an entirely new line of strategy in the treatment of neurological conditions, as well as cancer, infectious disease, and autoimmune diseases.

The genetic editing technique has contributed to new cancer therapies and has the potential to be used in curing inheritable diseases.

Two women were awarded the Nobel Prize in chemistry Wednesday for their pioneering work on genome editing, which has the life-saving potential to be used to cure genetic diseases.el Prize in chemistry Wednesday for their pioneering work on genome editing, which has the life-saving potential to be used to cure genetic diseases.el Prize in chemistry on Wednesday for developing a method for genome editing that could be used to cure many diseases.

Emmanuelle Charpentier and Jennifer A. Doudna developed the Crispr tool, which can change the DNA of animals, plants and microorganisms with high precision.